Cargando…

Age-based factors modulating the required thyroxine dose to achieve thyrotropin suppression in intermediate-and high-risk papillary thyroid cancer

BACKGROUND: Guidelines widely recommend thyrotropin suppression to reduce the risk of recurrence in intermediate- and high-risk papillary thyroid cancer (PTC) after total thyroidectomy. However, an insufficient or excessive dosage may result in a number of symptoms/complications especially in older...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ruo-Yun, Li, Ning, Tan, Hai-Long, Tang, Neng, Chen, Pei, Liu, Mian, Ou-Yang, Deng-Jie, Qin, Zi-En, Ai, Lei, Wei, Bo, Zhao, Ya-Xin, Chang, Shi, Huang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303814/ https://www.ncbi.nlm.nih.gov/pubmed/37388210 http://dx.doi.org/10.3389/fendo.2023.1126592

Ejemplares similares

Can Thyrotropin, Tri-Iodothyronine, and Thyroxine Hormones be Predictors of Cancer in Thyroid Lesions?
por: Khider, Mohamed O, et al.
Publicado: (2022)

Free Thyroxine Distinguishes Subclinical Hypothyroidism From Other Aging-Related Changes in Those With Isolated Elevated Thyrotropin
por: Abbey, Enoch J., et al.
Publicado: (2022)

Effect of Thyroxine and Thyrotropin on Bone Mineral Density in Postmenopausal Women: A Systematic Review
por: Poudel, Prakar, et al.
Publicado: (2022)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients
por: Papaleontiou, Maria, et al.
Publicado: (2016)

Follicular fluid thyroid autoantibodies, thyrotropin, free thyroxine levels and assisted reproductive technology outcome
por: Medenica, Sanja, et al.
Publicado: (2018)

The Association of Thyrotropin and Autoimmune Thyroid Disease in Developing Papillary Thyroid Cancer
por: Lee, I-Shuan, et al.
Publicado: (2017)

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Serum Thyroid Hormone Antibodies Are Frequent in Patients with Polyglandular Autoimmune Syndrome Type 3, Particularly in Those Who Require Thyroxine Treatment
por: Vita, Roberto, et al.
Publicado: (2017)

Advances in applied homeostatic modelling of the relationship between thyrotropin and free thyroxine
por: Hoermann, Rudolf, et al.
Publicado: (2017)

Levels of serum thyroxine, triidothyronine and thyrotropin in patients with acute myocardial infarction
por: Gulzar, Rukhsana, et al.
Publicado: (2018)

Daily requirement of softgel thyroxine is independent from gastric juice pH
por: Virili, Camilla, et al.
Publicado: (2022)

Thyroxine Supplementation in Pregnant Women After Thyroidectomy for Thyroid Cancer and Neonatal Birth Weight
por: Ding, Zheng, et al.
Publicado: (2021)

Serum Thyrotropin and Phase of the Menstrual Cycle
por: Benvenga, Salvatore, et al.
Publicado: (2017)

Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy
por: Ran, Bingyu, et al.
Publicado: (2022)

Simultaneous Coexistence of Thyrotropin-Prolactin-Secreting Adenoma and Papillary Thyroid Carcinoma
por: Safi, Somaya, et al.
Publicado: (2021)

Comprehensive analysis of the effect of Hashimoto’s thyroiditis on the diagnostic efficacy of preoperative ultrasonography on cervical lymph node lesions in papillary thyroid cancer
por: Tan, Hai-Long, et al.
Publicado: (2023)

Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma
por: Wang, Bin, et al.
Publicado: (2023)

Prognostic significance of inflammatory markers LMR, PLR, MPV, FIB in intermediate-and high-risk papillary thyroid carcinoma
por: Li, Canxiao, et al.
Publicado: (2022)

A Prognostic Model of Differentiated Thyroid Cancer Based on Up-Regulated Glycolysis-Related Genes
por: Wu, Min, et al.
Publicado: (2022)

Papillary Thyroid Carcinoma and Inflammation
por: Fugazzola, Laura, et al.
Publicado: (2011)

General Error Analysis in the Relationship between Free Thyroxine and Thyrotropin and Its Clinical Relevance
por: Goede, Simon L., et al.
Publicado: (2013)

Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling
por: Galuppini, Francesca, et al.
Publicado: (2022)

Preoperative Thyrotropin Serum Concentrations Gradually Increase from Benign Thyroid Nodules to Papillary Thyroid Microcarcinomas Then to Papillary Thyroid Cancers of Larger Size
por: Zafon, Carles, et al.
Publicado: (2012)

Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma
por: Ma, Teng, et al.
Publicado: (2023)

Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor
por: Thirunarayanan, Nanthakumar, et al.
Publicado: (2012)

Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture
por: Morgan, Sarah J., et al.
Publicado: (2016)

Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
por: Inaba, Hidefumi, et al.
Publicado: (2016)

The Role of Thyrotropin Receptor Activation in Adipogenesis and Modulation of Fat Phenotype
por: Draman, Mohd Shazli, et al.
Publicado: (2017)

Tanycytes and the Control of Thyrotropin-Releasing Hormone Flux Into Portal Capillaries
por: Rodríguez-Rodríguez, Adair, et al.
Publicado: (2019)

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021)

Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report
por: Yang, Jing, et al.
Publicado: (2017)

Benign thyroid nodules respond to a single administration of 0.3mg recombinant human thyrotropin with highly variable volume increase
por: Bountouris, Panagiotis, et al.
Publicado: (2023)

Commentary: Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture
por: Kyrilli, Aglaia, et al.
Publicado: (2017)

Thirty synchronous medullary and papillary thyroid carcinomas
por: Zhang, Daqi, et al.
Publicado: (2023)

Thyroid hormone receptor β sumoylation is required for thyrotropin regulation and thyroid hormone production
por: Ke, Sujie, et al.
Publicado: (2021)

Thyrotropin suppression therapy for papillary thyroid carcinoma with a huge recurred neck lymph node
por: Choi, Jung Bum, et al.
Publicado: (2020)

Standardization of Free Thyroxine and Harmonization of Thyrotropin Measurements: A Request for Input from Endocrinologists and Other Physicians
por: Thienpont, Linda M., et al.
Publicado: (2015)

Thyrotropin Regulates eNOS Expression in the Endothelium by PGRN Through Akt Pathway
por: Jiang, Fengwei, et al.
Publicado: (2018)

Thyroxine Replacement for Subfertile Females With Subclinical Hypothyroidism and Autoimmune Thyroiditis: A Systematic Review
por: Myneni, Revathi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ap5c5jpuim9m5cl6ip2723108e